Colon Cancer News and Research

Latest Colon Cancer News and Research

North American Menopause Society releases guidelines saying HRT beneficial for younger women

The North American Menopause Society on Thursday released a revised position statement that said the benefits of short-term hormone replacement therapy for treatment of menopausal women likely outweigh the risks for younger women, the Wall Street Journal reports.

28 Jan 2007

Fat-hormone leptin may enhance the growth of colonic cancers

Tests on three human colon cancer cell lines showed that the fat-hormone 'leptin' may enhance the growth of colonic cancers. This finding could show why obese people are at increased risk of colon cancer.

10 Jan 2007

A Trojan horse for gliomas

Gliomas are a group of brain tumors where the most common type is also the most aggressive one.

9 Jan 2007

Lifestyle decisions that may stave off onset of cancer

Personal choices, such as smoking and consumption of fatty foods, have long been linked to increased cancer risk. During recent years, scientists have been seeking to isolate a variety of lifestyle decisions that may stave off the onset of cancer or even reduce tumor formation in their early stages.

14 Nov 2006

A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas

In a dramatic demonstration of the power of nanotechnology, a team of investigators has designed a nanoscale, polymeric drug delivery vehicle that when loaded with a widely used anticancer agent cures colon cancer in mice with a single dose.

13 Nov 2006

Study suggests colonoscopy guidelines need to be revised

According to a new study the polyps in the colon which are often a precursor to colon cancer are 73 percent more common in men than in women.

2 Nov 2006

Lab-on-a-chip nanoscale array monitors cellular processes

Researchers at Tel-Aviv University in Israel have developed a lab-on-a-chip device that can incorporate enzymes and even living cells in a nanoscale array capable of monitoring electrochemical reactions.

30 Oct 2006

Confusion abounds on how to treat the menopause

The results in 2002 of a large U.S. study on hormone replacement therapy (HRT) in many respects left women confused and alarmed about the treatment for the menopause.

25 Oct 2006

ODC genetic variation impacts aspirin's effectiveness in preventing colon cancer

Dartmouth researchers are among a team of doctors that have learned more about how people may or may not benefit from taking aspirin in the effort to curb colon cancer.

24 Oct 2006

National Eye Institute to finance two-year study comparing effectiveness of treatments for macular degeneration

The National Eye Institute on Thursday said it will finance a two-year study comparing the effectiveness of Genentech's eye treatment Lucentis and cancer drug Avastin for treating wet age-related macular degeneration, the New York Times reports.

8 Oct 2006

FDA more cautious in approving new drugs after Vioxx

Many pharmaceutical companies and industry observers say that FDA is "quietly becoming more assertive about keeping new drugs off the market or refusing to approve new uses for existing medications" in response to criticism since the 2004 Vioxx recall, the New York Times reports.

3 Oct 2006

Curcumin useful in the fight against colorectal cancer

Looking for a cancer cure? Try the spice rack. In the last few years, that tactic has proved productive for researchers investigating turmeric, a curry spice used for centuries in Indian traditional medicine.

19 Sep 2006

Quality indicators for gastrointestinal endoscopic procedures

Defining measurements and identifying quality standards in the delivery of colonoscopic care is a major priority for the nation's leading gastrointestinal endoscopic healthcare association.

13 Sep 2006

Genetic code for breast and colon cancers

Johns Hopkins Kimmel Cancer Center scientists have completed the first draft of the genetic code for breast and colon cancers.

7 Sep 2006

VIOXX reduces risk of colorectal polyps

A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.

30 Aug 2006

Celebrex shown to reduce incidence of potentially pre-malignant colorectal polyps

An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex. and manufactured by Pfizer, significantly reduced recurrence of adenomas, or pre-malignant colon tumors - within three years of previous adenoma removal.

30 Aug 2006

Colon Cancer News and Research

Latest Colon Cancer News and Research

North American Menopause Society releases guidelines saying HRT beneficial for younger women

Fat-hormone leptin may enhance the growth of colonic cancers

A Trojan horse for gliomas

Lifestyle decisions that may stave off onset of cancer

A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas

Study suggests colonoscopy guidelines need to be revised

Lab-on-a-chip nanoscale array monitors cellular processes

Confusion abounds on how to treat the menopause

ODC genetic variation impacts aspirin's effectiveness in preventing colon cancer

National Eye Institute to finance two-year study comparing effectiveness of treatments for macular degeneration

FDA more cautious in approving new drugs after Vioxx

Curcumin useful in the fight against colorectal cancer

Quality indicators for gastrointestinal endoscopic procedures

Genetic code for breast and colon cancers

VIOXX reduces risk of colorectal polyps

Celebrex shown to reduce incidence of potentially pre-malignant colorectal polyps

Study shows diabetes link to colon cancer - smokers with type-2 diabetes face the greatest risk

Seven quality guidelines for breast, colorectal cancer care

Oxy-Q may help prevent colon cancer

Probiotic drinks - not all brands live up to claims

Industry Focus eBook - Oncology (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Colon Cancer News and Research

Latest Colon Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in